Entity > Corporation > US > New York City New York > Sage Therapeutics
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company dedicated to developing novel therapies that have the potential to transform the lives of people with debilitating brain diseases.
Sage Therapeutics' Specialises in CNS disorders, Neuroscience, Brain Health, Mental Health, and Brain Disorders: With the goal of improving brain health, Sage Therapeutics is breaking new ground. Their depression, neurology and neuropsychiatry franchise programmes aim to change the way brain disorders are viewed and treated.
Sage Therapeutics Has A Distinct Approach to Neuroscience Drug Development: Sage is committed to developing new drugs to treat life-changing brain disorders. Sage Therapeutics conducts clinical trials to determine whether our investigational drugs are safe and effective for patients with a particular disease, disorder or condition, which may enable us to seek the necessary regulatory approvals to provide broad access to these drugs.
Sage Therapeutics' Pipeline: Advancing a Leading Brain Health Portfolio: Sage Therapeutics is committed to addressing patients' unmet treatment needs by advancing product candidates from a robust development pipeline of potential therapies for brain disorders.
Sage Therapeutics' Foundation: Sage Therapeutics was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Sage Therapeutics' Mission and Values: To fearlessly pave the way to a world with better brain health. To pioneer life-changing brain health medicines to help everyone succeed. Sage's goal is to develop meaningful and differentiated drug candidates. They aim to discover new pathways to brain health by developing drugs that matter so patients can get better faster.
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Sage Therapeutics
| Company Attribute | Value |
| Address | StreetAddress: 215 1st St, AddressLocality: Cambridge, AddressRegion: Massachusetts, PostalCode: 2142, AddressCountry: United States |
| Founding Date | 2010 |
| Name | Sage Therapeutics |
| Number Of Employees | 471 |
| Revenue | $6,307,000 USD |
| Ticker Symbol | NASDAQ: SAGE |
| Url | sagerx |
| Wikidata | wikidata |
Sage Therapeutics
New York City, US
22 Sep 2023
Sage Therapeutics
Sage Therapeutics (Biotech company)
Sage is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain.
-
Stock price : SAGE (NASDAQ) $19.60 -0.30 (-1.51%)Sep 21, 4:00 PM EDT - Disclaimer
-
Headquarters : Massachusetts
-
CEO : Barry E Greene (Dec 2020–)
-
Founded : 2010
-
Subsidiaries : Sage Therapeutics, Inc., Sage Therapeutics B.V., MORE
-
Founders : Douglas Covey, Steven Paul
| Entity Home | Kalicube Pro Entity Page |